Alert detail
LCD L37663: MolDX: EndoPredict® Breast Cancer Gene Expression Test — WPS
What changed
WPS finalizes EndoPredict® breast cancer genomic test coverage (eff. 5/1/25)
Who’s affected: Oncology billing teams · Effective: May 1, 2025
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
This change affects 6 billing codes.
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.